HRP-induced wide wavelength-tunable in situ fluorogenic system and its immunoassay for cTnI in clinical samples

Key Points

• The fluorogenic system enables wavelength tuning for precise cTnI detection with high sensitivity.
• Key evidence shows the system can detect cTnI concentrations effectively in clinical samples.
• Analysis utilizes an immunoassay approach with HRP, enhancing detection capabilities for biomarkers.
• Potentially improves diagnostic methods for heart conditions; further validation in larger clinical settings needed.